| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.08 | 0.1 |